Locus heterogeneity means the same disease, or one that looks clinically identical, can be caused by variants in different genes: oculocutaneous albinism (TYR, OCA2, TYRP1, SLC45A2), retinitis pigmentosa (more than 130 genes), osteogenesis imperfecta (COL1A1, COL1A2 and rarer recessive genes) and familial hypercholesterolemia (LDLR, APOB, PCSK9). Allelic heterogeneity is the counterpart: different variants in the same gene cause the same disease, as in beta-thalassemia (hundreds of HBB variants) and cystic fibrosis (CFTR only). Two stem clues settle most questions: "negative for the common variant" of a known disease gene points to allelic heterogeneity, while a variant in a different gene, or two parents with the same recessive disorder who have unaffected children, points to locus heterogeneity.
The vignette
A woman and a man who both have oculocutaneous albinism ask for genetic counseling before a fourth pregnancy. Each was born to unaffected parents. The woman has had white hair and very pale skin since birth; the man has light brown hair and pale skin. Both have nystagmus and reduced visual acuity. All three of their children have normal skin, hair and eye pigmentation, and paternity is confirmed. In both families, albinism follows an autosomal recessive pattern.
Which of the following best explains the children's normal pigmentation?
A. Allelic heterogeneity B. Incomplete penetrance C. Locus heterogeneity D. Phenotypic heterogeneity E. Pleiotropy F. Variable expressivity
Answer: C. Locus heterogeneity.
Why C is right: the parents' variants are in different genes
Oculocutaneous albinism (OCA) is one phenotype with several autosomal recessive types, each from a different gene: OCA1 (TYR), OCA2 (OCA2), OCA3 (TYRP1) and OCA4 (SLC45A2), plus several rarer types. The hair colors are only a hint: the mother's white hair fits OCA1, and the father's light brown hair fits a milder type such as OCA2 (OCA4 looks similar). The proof is the children. If she carries two TYR variants and he carries two OCA2 variants, every child gets one variant copy at each locus plus a working copy from the other parent:
| TYR locus | OCA2 locus | Pigmentation | |
|---|---|---|---|
| Mother (OCA1) | Two variant copies | Two normal copies | Albinism |
| Father (OCA2) | Two normal copies | Two variant copies | Albinism |
| Every child | One variant, one normal | One variant, one normal | Normal (carrier at both loci) |
The two defects complement each other. If both parents had variants in the same gene, every child would inherit two variant copies of that gene and would be affected, so three unaffected children (with paternity confirmed) place the parents' variants in different genes. Testing TYR and OCA2 would confirm the mechanism; the autosomal recessive inheritance review covers the carrier math.
Why every other choice is wrong
A. Allelic heterogeneity. Different variants in the same gene cause one disease. Beta-thalassemia is the classic: hundreds of HBB variants, either β0 (no beta-globin) or β+ (reduced beta-globin), all cause beta-thalassemia. Why wrong: if both parents had different TYR variants, each child would be a compound heterozygote (one variant from each parent) and would still have albinism. Allelic heterogeneity cannot produce unaffected children here.
B. Incomplete penetrance. Some people with a disease genotype show no signs. MedlinePlus uses BRCA1 and BRCA2: many carriers develop cancer during their lifetime, but some do not. Why wrong: invoking it would require all three children to carry an albinism genotype yet stay fully pigmented. Different genes explain the result without that assumption.
D. Phenotypic heterogeneity. One gene causes different diseases. RET loss-of-function variants cause Hirschsprung disease, whereas gain-of-function variants cause multiple endocrine neoplasia type 2 (MEN syndromes); HBB gives sickle cell disease (Glu6Val) or beta-thalassemia. Why wrong: both parents have the same disorder, so nothing here involves one gene causing two different diseases, and the term says nothing about why the children escaped albinism.
E. Pleiotropy. One gene affects several seemingly unrelated systems in the same person. Untreated phenylketonuria (PAH) causes intellectual disability, seizures, a musty odor, eczema and lighter skin and hair. Why wrong: pleiotropy describes how widely one genotype acts; it does not explain why a trait disappears in the next generation.
F. Variable expressivity. People with the same genetic condition have different severity or features. In Marfan syndrome, some people are only tall and thin with long fingers, while others have life-threatening aortic disease; NF1 is the other classic. Why wrong: expressivity varies only among people who have the condition; these children do not have it at all.
The six terms on one page
| Term | Gene | Phenotype | Classic example | Stem clue |
|---|---|---|---|---|
| Locus heterogeneity | Different genes | Same disease | Albinism, retinitis pigmentosa, osteogenesis imperfecta, familial hypercholesterolemia | "Usual gene normal; variant found in another gene"; recessive parents with unaffected children |
| Allelic heterogeneity | Same gene, different variants | Same disease | Beta-thalassemia (HBB), cystic fibrosis (CFTR) | "Negative for the most common variant" |
| Phenotypic heterogeneity | Same gene | Different diseases | RET (Hirschsprung vs MEN2), HBB (sickle cell vs beta-thalassemia), CFTR (CF vs isolated CBAVD) | "Same gene, different disorder" |
| Pleiotropy | One gene | Many systems in one person | PKU, Marfan syndrome | One variant explains the eye, skeleton and heart |
| Variable expressivity | Same condition | Different severity | Marfan syndrome, NF1 | Relatives with the same variant, different severity |
| Incomplete penetrance | Genotype present | Absent in some carriers | BRCA1/BRCA2 | Unaffected obligate carrier; "skipped" generation |
For more on the last two rows, see penetrance vs expressivity.
Locus heterogeneity examples worth memorizing
| Disease | Genes | Why it matters |
|---|---|---|
| Oculocutaneous albinism | TYR (OCA1), OCA2 (OCA2), TYRP1 (OCA3), SLC45A2 (OCA4), plus rarer types | All autosomal recessive, so affected parents can have unaffected children |
| Retinitis pigmentosa | More than 130 genes; RHO most often in autosomal dominant, USH2A in autosomal recessive, RPGR in X-linked families | One disease, three inheritance patterns |
| Osteogenesis imperfecta | COL1A1 or COL1A2 in about 90% (autosomal dominant); CRTAP, P3H1, PPIB, SERPINF1 and others (autosomal recessive); a rare X-linked form | Unaffected parents can have a child with a recessive form (OI review) |
| Familial hypercholesterolemia | LDLR (most common), APOB, PCSK9 (autosomal dominant); LDLRAP1 (autosomal recessive) | Different genes, one pathway: less LDL cleared by the LDL receptor |
| Limb-girdle muscular dystrophy | More than 32 genes, including the sarcoglycan genes (SGCA, SGCB, SGCG, SGCD); mostly autosomal recessive | Proximal weakness and calf enlargement can mimic Duchenne, but dystrophin (DMD) testing is normal |
Exam point: because the genes differ, locus heterogeneity can change the inheritance pattern between families with the "same" disease. One family's retinitis pigmentosa is X-linked and another's is autosomal dominant; most osteogenesis imperfecta is dominant, but some forms are recessive.
How USMLE tests it (and the traps)
- Read for the gene, not the disease name. Different gene means locus heterogeneity; same gene with a different variant means allelic heterogeneity.
- A negative targeted test is not a different gene. It usually means a different variant in the same gene, so the next step is full sequencing of that gene.
- Unaffected children of two affected recessive parents means the parents' variants are in different genes.
- Pleiotropy vs variable expressivity. Pleiotropy is breadth in one person (PKU affects brain, skin and odor); variable expressivity is a range of severity across people with the same condition.
- Don't confuse with anticipation, earlier or more severe disease in successive generations from repeat expansion (anticipation question).
Second case: when the answer is allelic heterogeneity
A 6-year-old boy has a chronic productive cough, recurrent sinus and lung infections, greasy stools and poor weight gain. Sweat chloride is 88 mmol/L on two occasions. A targeted test for F508del, the most common CFTR variant, is negative. His parents ask how he can have cystic fibrosis if "the gene test was negative." Which of the following best explains this result?
A. Allelic heterogeneity B. Anticipation C. Locus heterogeneity D. Variable expressivity E. Incomplete penetrance
Answer: A. Allelic heterogeneity. Symptoms plus a sweat chloride of 60 mmol/L or more establish CF. CF is a disease of one gene, CFTR, but more than 2,000 CFTR variants have been reported and hundreds are classified as CF-causing, so a test for one variant (or a short panel) can miss his. Sequencing the whole gene detects about 97-98% of pathogenic variants, and deletion/duplication analysis finds up to 2-3% more.
- B: anticipation comes from repeat expansions (Huntington disease, myotonic dystrophy, fragile X), and CF is not a repeat disorder.
- C: tempting, because "gene test negative" sounds like "different gene", but no second gene causes CF. The negative test reflects which variants were tested, not a different locus.
- D: variable expressivity describes different severity among people with the same genetic condition; it does not explain a negative test.
- E: incomplete penetrance describes an unaffected carrier; this boy clearly has the disease.
Key takeaways
- Locus heterogeneity: different genes, same disease. Know albinism, retinitis pigmentosa, osteogenesis imperfecta and familial hypercholesterolemia.
- Allelic heterogeneity: same gene, different variants, same disease. Know beta-thalassemia (HBB) and cystic fibrosis (CFTR).
- Phenotypic heterogeneity: same gene, different diseases (RET: Hirschsprung vs MEN2).
- Pleiotropy: one gene, many systems in one person (PKU). Variable expressivity: same condition, different severity (Marfan, NF1). Incomplete penetrance: genotype without phenotype (BRCA1/BRCA2).
- Two affected recessive parents with unaffected children = variants in different genes (complementation).
- "Negative for the common variant" = allelic heterogeneity; sequence the whole gene next.
Sources
- Genetic heterogeneity — NCI Dictionary of Genetics Terms, National Cancer Institute
- Oculocutaneous albinism — MedlinePlus Genetics, National Library of Medicine (2024)
- Retinitis pigmentosa — MedlinePlus Genetics, National Library of Medicine (2026)
- Osteogenesis imperfecta — MedlinePlus Genetics, National Library of Medicine (2020)
- Familial hypercholesterolemia — MedlinePlus Genetics, National Library of Medicine (2020)
- Limb-girdle muscular dystrophy — MedlinePlus Genetics, National Library of Medicine (2025)
- HBB gene — MedlinePlus Genetics, National Library of Medicine (2024)
- Cystic Fibrosis — GeneReviews, NCBI Bookshelf (2024)
- Diversity of CFTR variants across ancestries characterized using 454,727 UK Biobank whole exome sequences — Genome Medicine (Ideozu et al., 2024)
- What are reduced penetrance and variable expressivity? — MedlinePlus Genetics (2021)
- RET gene — MedlinePlus Genetics, National Library of Medicine (2018)
- Phenylketonuria — MedlinePlus Genetics, National Library of Medicine (2023)
Frequently Asked Questions
What is locus heterogeneity?
Locus heterogeneity means that variants in different genes, at different chromosomal loci, cause the same or a clinically indistinguishable disease. Classic examples are oculocutaneous albinism (TYR, OCA2, TYRP1, SLC45A2), retinitis pigmentosa (more than 130 genes), osteogenesis imperfecta (COL1A1, COL1A2 and several recessive genes) and familial hypercholesterolemia (LDLR, APOB, PCSK9). Because the genes differ, the inheritance pattern can also differ between families with the same diagnosis.
What is the difference between locus heterogeneity and allelic heterogeneity?
The question is whether one gene or several are involved. Locus heterogeneity is different genes causing the same disease, such as albinism from TYR in one family and OCA2 in another. Allelic heterogeneity is different variants in the same gene causing the same disease, such as the hundreds of HBB variants that cause beta-thalassemia or the many CFTR variants that cause cystic fibrosis. On exams, a negative test for the common variant of a known gene points to allelic heterogeneity.
How can two parents with albinism have a child with normal pigmentation?
If the parents' albinism comes from variants in different genes, for example TYR in one parent and OCA2 in the other, each child inherits one variant and one working copy of each gene. The children are carriers at both loci and have normal pigmentation, because the working copies complement each other. This is locus heterogeneity. If both parents had variants in the same gene, every child would inherit two variant copies and would have albinism.
Why is cystic fibrosis an example of allelic heterogeneity and not locus heterogeneity?
Cystic fibrosis is caused by variants in only one gene, CFTR, but more than 2,000 CFTR variants have been reported, and hundreds are classified as CF-causing. That is allelic heterogeneity. A test for F508del alone, or a small panel, can therefore miss a child's variants even when symptoms and a sweat chloride of 60 mmol/L or more establish the diagnosis. The next step is full CFTR sequencing, not a search for a different gene.
What is the difference between pleiotropy and phenotypic heterogeneity?
Pleiotropy means one gene affects several seemingly unrelated systems in the same person, as in untreated phenylketonuria, which causes intellectual disability, seizures, a musty odor, eczema and light skin and hair. Phenotypic heterogeneity means different variants in one gene cause different diseases, as with RET, where loss-of-function variants cause Hirschsprung disease and gain-of-function variants cause multiple endocrine neoplasia type 2. Pleiotropy is breadth within one disorder; phenotypic heterogeneity is one gene with two or more disorders.
How do variable expressivity and incomplete penetrance differ?
Both describe people who share a disease genotype but differ clinically. In variable expressivity, people with the genotype are affected to different degrees: in Marfan syndrome, one person is only tall and thin with long fingers, while a relative has life-threatening aortic disease. In incomplete penetrance, some people with the genotype show no signs at all, as with BRCA1 or BRCA2 variant carriers who never develop cancer. An unaffected obligate carrier in a pedigree suggests incomplete penetrance.